B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ATP1A1

MOLECULAR TARGET

ATPase Na+/K+ transporting subunit alpha 1

UniProt: P05023NCBI Gene: 4766 compounds

ATP1A1 (ATPase Na+/K+ transporting subunit alpha 1) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ATP1A1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Digoxin2.309
2Digitoxigenin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide.2.087
3Ouabain1.795
4Digitoxin1.393
5Deslanoside Deacetyllanatoside C.0.691
6Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide.0.691

About ATP1A1 as a Drug Target

ATP1A1 (ATPase Na+/K+ transporting subunit alpha 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented ATP1A1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ATP1A1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.